R

Recludix Pharma

Biotechnology📍 Cambridge, MA

Recludix Pharma develops novel SH2 domain inhibitors targeting STAT3 and STAT6 for cancer and inflammatory diseases.

Open Positions at Recludix Pharma

0 positions available

No open positions at the moment

Check back later for new opportunities!